Skip to main content

Advertisement

Table 3 Differences in the amount/quantity of administered allogeneic blood products, coagulation factors and resuscitation fluids between the propensity score matched groups (LUKS: Cantonal Hospital Lucerne, USZ: University Hospital Zurich)

From: Comparison of two different coagulation algorithms on the use of allogenic blood products and coagulation factors in severely injured trauma patients: a retrospective, multicentre, observational study

  USZ (n = 172) LUKS (n = 172) p-value
RBC (U) 0.5 (1.9) 1.5 (3.9) < 0.001
FFP (U) 0.1 (0.6) 0.4 (2.2) 0.15
PLT (U) 0.1 (0.3) 0.1 (0.4) 0.32
FFP:RBC (ratio) 0.1 (0.3) 0.1 (0.3) 0.91
Fibrinogen (g) 1.1 (2.6) 1.5 (3.0) 0.05
PCC (IU) 124 (408) 454 (1011) < 0.001
Factor XIII (IU) 116 (388) 51 (282) 0.04
Crystalloid (ml) 2130 (2642) 3944 (4064) < 0.001
Starch (ml) 13 (94) 146 (319) < 0.001
Gelatin (ml) 347 (722) 142 (392) 0.004
  1. Data reported as mean (SD). The p-value (Mann-Whitney test) was calculated between the groups. Level of significance 0.05
  2. FFP fresh frozen plasma, FXIII coagulation factor XIII, PCC 4 factor prothrombin complex concentrate, PLT platelet concentrate, RBC red blood cell concentrate